PMC:7787218 / 8197-8510 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7787218","sourcedb":"PMC","sourceid":"7787218","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7787218","text":"ated with second and subsequent injections.8\nPEG is a compound used as an excipient in medications and has been implicated as a rare, “hidden danger” cause of IgE-mediated reactions and recurrent anaphylaxis.9 The presence of lipid PEG 2000 in the mRNA vaccines has led to concern about the possibility that this ","tracks":[{"project":"LitCovid-PD-HP","denotations":[{"id":"T32","span":{"begin":196,"end":207},"obj":"Phenotype"}],"attributes":[{"id":"A32","pred":"hp_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/HP_0100845"},{"subj":"T32","pred":"source","obj":"LitCovid-PD-HP"}]},{"project":"LitCovid-PubTator","denotations":[{"id":"155","span":{"begin":45,"end":48},"obj":"Chemical"},{"id":"156","span":{"begin":226,"end":231},"obj":"Chemical"},{"id":"157","span":{"begin":232,"end":240},"obj":"Chemical"}],"attributes":[{"id":"A155","pred":"tao:has_database_id","subj":"155","obj":"MESH:D011092"},{"id":"A156","pred":"tao:has_database_id","subj":"156","obj":"MESH:D008055"},{"id":"A157","pred":"tao:has_database_id","subj":"157","obj":"MESH:C000595210"},{"subj":"155","pred":"source","obj":"LitCovid-PubTator"},{"subj":"156","pred":"source","obj":"LitCovid-PubTator"},{"subj":"157","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-HP","color":"#94ec93","default":true},{"id":"LitCovid-PubTator","color":"#ec93ae"}]}]}}